Requires periodic reviews of pending applications for material change in the coverage status of certain matters relative to new health technology assessment or medical evidence.
Impact
If enacted, A11025 will significantly enhance the procedural framework for assessing health technologies and the evidence supporting their coverage. It mandates that the Department of Health publish receipt of applications and the scheduling of reviews on its website, fostering greater public awareness and accountability. Additionally, it implies a structured approach to evidence collection and assessment, clarifying the grounds for coverage changes and ensuring that stakeholders can participate in the review process.
Summary
A11025 is a bill introduced in the New York State Assembly aimed at amending the social services law to require periodic reviews of pending applications for material changes in the coverage status related to new health technology assessments or medical evidence. The bill obligates the commissioner to conduct these reviews in consultation with a committee and ensures that applicants are notified of any deficiencies within thirty days of submission. This process seeks to enhance transparency and efficiency in the evaluation of health technologies and services for coverage decisions.
Contention
Potential points of contention may arise from the added bureaucracy and potential delays that critics may argue could be introduced by the periodic review requirement. Stakeholders, such as health care providers and technology manufacturers, may have differing views on the adequacy of the proposed processes and timelines for review. Proponents of the bill might advocate that increased scrutiny through systematic evidence-based assessments will ultimately lead to better patient outcomes and more prudent coverage decisions, while opponents may caution against bureaucratic overreach that might stifle innovation or delay access to beneficial health technologies.
Same As
Requires periodic reviews of pending applications for material change in the coverage status of certain matters relative to new health technology assessment or medical evidence.
Requires periodic reviews of pending applications for material change in the coverage status of certain matters relative to new health technology assessment or medical evidence.
Relates to utilization review program standards; requires use of evidence-based and peer reviewed clinical review criteria; relates to prescription drug formulary changes and pre-authorization for certain health care services.
Relates to utilization review program standards; requires use of evidence-based and peer reviewed clinical review criteria; relates to prescription drug formulary changes and pre-authorization for certain health care services.
Relates to utilization review program standards; requires use of evidence-based and peer reviewed clinical review criteria; relates to prescription drug formulary changes and pre-authorization for certain health care services.
Ensures Medicaid spending results in real access to medical care by increasing transparency in Medicaid managed care network adequacy reviews and safeguarding continuity of care in light of recent major provider network withdrawals.
Requires the office for the prevention of domestic violence provide informational materials on removing an abuser's access to a smart home and the use of other technology for harassment.
Requires the office for the prevention of domestic violence provide informational materials on removing an abuser's access to a smart home and the use of other technology for harassment.